Form 4 for OBIO Orchestra BioMed Holdings, Inc.
Accepted 2026-09-02 16:15:20 ET · period of report 2026-09-01 · accession 0001104659-26-104739 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-02 16:15 | 2026-09-01 | OBIO | Sherman Darren | See Remarks, Dir | S - Sale | $4.94 | -15.0K | 1.13M | -1% | -$74.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.0001 per share ("Common Stock") | 2026-09-01 | S | D | 15,000 | $4.94 | 1,134,402 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 18, 2025. (F2) The price reported is a weighted average price. These shares were disposed in multiple transactions at prices ranging from $4.88 to $5.06. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares disposed at each separate price within the range set forth in this footnote. |